Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Medtronic
Covington
US Department of Justice
Accenture
Farmers Insurance
Johnson and Johnson
Healthtrust

Generated: November 13, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021487

« Back to Dashboard

NDA 021487 describes NAMENDA, which is a drug marketed by Allergan Sales Llc and Forest Labs Llc and is included in three NDAs. It is available from eight suppliers. There are seven patents protecting this drug and five Paragraph IV challenges. Additional details are available on the NAMENDA profile page.

The generic ingredient in NAMENDA is memantine hydrochloride. There are twenty-eight drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the memantine hydrochloride profile page.
Summary for 021487
Tradename:NAMENDA
Applicant:Allergan Sales Llc
Ingredient:memantine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 021487
Mechanism of ActionNMDA Receptor Antagonists
Medical Subject Heading (MeSH) Categories for 021487
Suppliers and Packaging for NDA: 021487
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NAMENDA memantine hydrochloride TABLET;ORAL 021487 NDA Allergan, Inc 0456-3200 0456-3200-14 1 KIT in 1 BLISTER PACK (0456-3200-14)
NAMENDA memantine hydrochloride TABLET;ORAL 021487 NDA Allergan, Inc 0456-3205 0456-3205-60 60 TABLET in 1 BOTTLE (0456-3205-60)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Oct 16, 2003TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Oct 16, 2003TE:ABRLD:Yes

Expired US Patents for NDA 021487

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan Sales Llc NAMENDA memantine hydrochloride TABLET;ORAL 021487-001 Oct 16, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc NAMENDA memantine hydrochloride TABLET;ORAL 021487-002 Oct 16, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc NAMENDA memantine hydrochloride TABLET;ORAL 021487-002 Oct 16, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc NAMENDA memantine hydrochloride TABLET;ORAL 021487-001 Oct 16, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Covington
Cerilliant
Queensland Health
Colorcon
Chubb
Fuji
Deloitte
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.